Bench-Scale Bioreactors Incorporate Single-Use Elements, Linearly Scalable Actuators, and Sensors Bench-scale bioreactors ranging in volume from about 2 L to 20 L have become indispensable as ...

In its collective efforts to develop new drugs, the pharmaceuticals industry is making increasing use of biotechnology based on the application of natural biological transformation processes. One of ...

New Brunswick Scientific has introduced a benchtop cell culture bioreactor that combines the benefits of single-use technology with the trusted performance and true scalability of a stirred-tank ...

New expandable benchtop workstation with unique single-use bioreactor design offers a simple approach to process development for fermentation and cell culture Sartorius Stedim Biotech (SSB) introduced ...

Researchers at Hannover Medical School have developed a benchtop bioreactor system that can generate up to 40 million human macrophages per week from induced pluripotent stem cells. The medium-scale ...

A single-use benchtop bioreactor ready to use out of the box is expected to launch next month, according to Massachusetts manufacturer Millipore. The 3-liter CellReady Bioreactor is part of the ...

The BioXplorer 100 from H.E.L is a multi-bioreactor system that has been specifically developed for the optimization of aerobic fermentations. Having a working volume as low as 50 mL, the BioXplorer ...

From the company that has brought you over 40 years of excellence in laboratory pharmaceutical instruments, Distek, Inc. is proud to introduce the BIOne 1250 Bioprocess Control Station. BIOne ...

Single-Use Systems Slowly but Surely Gaining Acceptance in Critial Unit Operations Disposable bioreactors have become the vanguard of single-use processing, a litmus test of sorts for the acceptance ...

A benchtop bioreactor system developed at Hannover Medical School can produce up to 40 million human immune cells per week from stem cells, according to a protocol published in Nature Protocols in ...

Researchers at Hannover Medical School (MHH) have developed a method for the efficient production of human immune cells, such as macrophages, in medium-sized bioreactors. These immune cells can be ...